Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types. (16th October 2015)

Record Type:
Journal Article
Title:
Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types. (16th October 2015)
Main Title:
Early preclinical development of PQR309, a novel balanced dual PI3K/mTOR inhibitor for treatment of various cancer types
Authors:
Ettlin, R.
Dieterle, W.
Fabbro, D.
Hebeisen, P.
Beaufils, F.
Hillmann, P.
Stumm, M.
Dimitrijević, S.
Wymann, M.
Cmiljanovic, N.
Giese, B.
Cmiljanovic, V.
Abstract:
Is Part Of:
Toxicology letters. Volume 238(2015)Supplement
Journal:
Toxicology letters
Issue:
Volume 238(2015)Supplement
Issue Display:
Volume 238, Issue 2015 (2015)
Year:
2015
Volume:
238
Issue:
2015
Issue Sort Value:
2015-0238-2015-0000
Page Start:
S337
Page End:
S338
Publication Date:
2015-10-16
Subjects:
Toxicology -- Periodicals
363.179
Journal URLs:
http://www.sciencedirect.com/science/journal/03784274 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/j.toxlet.2015.08.963 ↗
Languages:
English
ISSNs:
0378-4274
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 8873.042000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
9088.xml